Knowing the results of psychedelics on human brain networks is crucial to unlocking their therapeutic mechanisms. In humans, in the roughly six?hour period of action, psilocybin increases glutamate signalling and glucose metabolism19,twenty,21, broadly decreases the power of electrophysiological signals22, lessens hemodynamic fluctuations23 and dec